Patients younger than age 60 with Gleason 8-10 disease who had upfront surgery versus radiation therapy had a 63% lower risk of prostate cancer-specific mortality.
A study suggests HIMRT may have some advantages over CIMRT for treating men with localized prostate cancer.
New multidisciplinary guideline for early-stage prostate cancer developed by 3 professional societies.
The 3-year survival rate was 81% for patients who underwent EBRT plus standard care vs 73% for those who had standard care alone.
Trials show high survival rates, freedom from recurrence for low-, intermediate-risk prostate cancer.
Radiation dose not impacted with light or moderate use of skin treatments, regardless of beam energy, incidence
Benefit of palliative radiation for bone metastasis across age groups; older age should not preclude tx.
Researchers observed reductions in biochemical failure and distant metastasis rates in patients who had dose-escalated radiation therapy.
In a study, extremely dose-escalated radiotherapy combined with androgen deprivation therapy offered the best cancer-specific survival among men with Gleason 9-10 prostate cancer.
In a study, the 17-year prostate cancer-specific and biochemical failure-free survival rates were 97% and 79%, respectively.
Adjuvant radiotherapy was associated with lower risks for biochemical failure and distant metastases and increased overall survival in patients with adverse pathologic features found after radical prostatectomy.
The locoregional recurrence-free survival rate at 2 years was significantly higher for patients treated with chemotherapy plus RT versus those treated with chemotherapy alone.
Patients who have to travel longer distances for prostate cancer treatment are more likely to receive stereotactic body radiotherapy.
Certain chemotherapies might shorten telomeres and alter microRNA.
Definitive comparative effectiveness data are lacking for salvage prostatectomy or salvage cryotherapy.
Among patients with high-risk prostate cancer, investigators observe no significant difference in cancer-related death risk between radiotherapy and radical prostatectomy.
A negative mpMRI is associated with a higher risk for PSA recurrence and metastasis following salvage radiotherapy for recurrent prostate cancer after radical prostatectomy.
Physicians who treat patients with high-risk prostate cancer remain uncertain as to the optimal treatment approach, in part due to difficulty in interpreting study data.
Biochemical failure and prostate cancer-specific mortality rates were 13.3% and 4.9% at 10 years, respectively.
Use of intensity-modulated radiation therapy for prostate cancer increased from 3.5% to 64% from 2002 to 2012.
The researchers found that there was no difference between the 6- and 2-fraction groups in baseline and post-implantation IPSS scores.
Patients are more likely to receive intensity-modulated radiation therapy if they are managed by urology practices with an ownership interest in the modality, study finds.
Radical cystectomy is associated with better survival, but findings suggest BPT may produce acceptable oncologic outcomes in appropriately selected patients.
63% of patients were managed initially with observation.
Radiotherapy for prostate cancer patients with persistently elevated PSA after radical surgery improved survival only among those with worse pathologic characteristics.
Younger patients who chose surgery vs radiation for initial treatment had a 48% survival advantage.
New findings establish single-dose radiotherapy as the standard of care for metastatic spinal canal compression, at least for patients with a short life expectancy, researcher says.
Urinary incontinence and diminished sexual function were common after a median follow-up of nearly 15 years, study finds.
Men who attended yoga classes had less fatigue and better sexual and urinary function than those in the comparison group.
Study compared PCa patients who underwent surgery or radiation treatment with a matched group of non-cancer controls.
Renal and Urology News Articles
- Low Vitamin D Tied to Risk for Renal Hyperfiltration in Healthy Adults
- Novel Albuminuria Endpoints May Improve CKD Progression Trials
- Overactive Bladder Linked to Prostate Cancer ADT
- Second-Line Antidiabetic Meds May Impact Cardiovascular Risk
- Hemodialysis Patients May Benefit by Staying on Loop Diuretics
- FDA Down to 5 Weeks of Funding to Review New Drug Applications
- Short Sleep Duration Linked to Higher Atherosclerotic Burden
- High Uric Acid Predicts AKI, Mortality in Hospitalized Patients
- PCa Phenotype May Predict Response to Immune Checkpoint Blockade
- Roxadustat Effective in Chronic Kidney Disease Patients With Anemia
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)